Dg. Bailey et al., ERYTHROMYCIN-FELODIPINE INTERACTION - MAGNITUDE, MECHANISM, AND COMPARISON WITH GRAPEFRUIT JUICE, Clinical pharmacology and therapeutics, 60(1), 1996, pp. 25-33
Objective: To investigate a potentially marked effect by erythromycin
on felodipine pharmacokinetics, to characterize the mechanism, and to
compare the interaction with that between grapefruit juice and felodip
ine, Methods: Felodipine, 10 mg extended release, was administered wit
h 250 mi water, 250 mg erythromycin, or 250 mi grapefruit juice in a r
andomized crossover study of 12 healthy men. Erythromycin base, 250 mg
four times a day, was started the day before and continued on that st
udy day, Pharmacokinetic values of felodipine, the primary metabolite
dehydrofelodipine, and the major secondary derivative M3 metabolite we
re studied. Results: Compared with water, erythromycin produced severa
lfold higher felodipine area under the plasma drug concentration-time
profile (AUG), plasma peak drug concentrations (C-max), and apparent e
limination half-life (t(1/2)); however, the effect was variable among
individuals. Erythromycin augmented dehydrofelodipine AUC, C-max, and
t(1/2) but decreased dehydrofelodipine/felodipine ratios. The AUC of t
he M3 metabolite and the M3 metabolite/dehydrofelodipine ratios were r
educed, These findings support inhibition of both metabolic pathways l
ikely mediated by CPP3A4. Grapefruit juice produced similar mean effec
ts but did not prolong felodipine or dehydrofelodipine t(1/2). Individ
ually, felodipine AUC with erythromycin was greater than or similar to
that with grapefruit juice. Relative felodipine AUC (erythromycin com
pared with grapefruit juice) correlated with relative felodipine C-max
but not with relative felodipine t(1/2), suggesting felodipine AUC di
ffered between these treatments, mainly from factors affecting presyst
emic drug elimination. Conclusions: Erythromycin produced an important
pharmacokinetic interaction with felodipine by inhibition of drug met
abolism, Although erythromycin and grapefruit juice shared a common me
chanism, erythromycin likely reduced felodipine biotransformation at t
he gut wall and liver, whereas single-dose grapefruit juice had an eff
ect mainly at the gut wall.